Cite
HARVARD Citation
Jonasova, A. et al. (2018). Lenalidomide treatment in lower risk myelodysplastic syndromes—The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients). Leukemia research. pp. 12-17. [Online].